Aberrantly expressed cytokeratin 1, a tumor-associated autoantigen in papillary thyroid carcinoma
- 9 October 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 73 (2) , 171-177
- https://doi.org/10.1002/(sici)1097-0215(19971009)73:2<171::aid-ijc1>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinomaHuman Pathology, 1996
- Genetically Engineered Tumor VaccinesAnnals of the New York Academy of Sciences, 1993
- Phenotypic and Functional Analysis at the Clonal Level of Infiltrating T Lymphocytes in Papillary Carcinoma of the Thyroid: Prevalence of Cytolytic T Cells with Natural Killer-Like or Lymphokine-Activated Killer Activity*Journal of Clinical Endocrinology & Metabolism, 1989
- Lymphocytic infiltration in juvenile thyroid carcinomaCancer, 1988
- HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumorsClinical Immunology and Immunopathology, 1988
- Occurrence of Thyrocyte HLA Class II Expression in a Wide Variety of Thyroid Diseases: Relationship With Lymphocytic Infiltration and Thyroid AutoantibodiesJournal of Clinical Endocrinology & Metabolism, 1988
- Expression of intermediate filament proteins in normal and diseased thyroid glands.Journal of Clinical Pathology, 1987
- Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibodyNature, 1981
- Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibodyCell, 1981
- RELATION OF THYROID NEOPLASMS TO HASHIMOTO DISEASE OF THE THYROID GLANDArchives of Surgery, 1955